Yuan Meng

affiliation not provided to SSRN

No Address Available

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

27

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Osimertinib Increase Immune Checkpoint Inhibitors-Related Severe Adverse Events Via Activating the Il-6/Jak/Stat3 Pathway of Egfr-Positive Macrophages

Number of pages: 14 Posted: 05 Feb 2024
Yuan Li, Yanping Chen, Yuan Meng, Ziqing Zeng, Meng Shen, Fan Yang and Xiubao Ren
affiliation not provided to SSRN, Fujian Medical University - Fujian Provincial Hospital, affiliation not provided to SSRN, Tianjin Medical University - Immunology Laboratory, affiliation not provided to SSRN, Tianjin Medical University and Tianjin Medical University - Immunology Laboratory
Downloads 27 (1,080,272)

Abstract:

Loading...

Osimertinib, ICIs, irAEs, EGFR-positive macrophages, IL-6/JAK/STAT3